Malvern Panalytical is a proud sponsor of National University of Singapore's (NUS) virtual conference "Explain my research" virtual conference which focuses on drug delivery and precision medicine. During this conference, you will hear from an international line-up of distinguished speakers as they discuss their latest research and outcomes relating to future health, particle characterization, targeted gene delivery systems, and precision medicine. Also look forward to a showcase of 2 cutting-edged startups from NUS!
Day 1 will see the release of short, 10-min webinars from researchers worldwide. The secret portal website link will only be released to registered participants. Input your burning questions into the forum and get ready for Day 2!
Day 2 gives you the opportunity to interact with many of these distinguished speakers LIVE at a panel. Zoom link will be released only to registered participants.
During this virtual conference, Dr Michael Caves gives a presentation ‘Challenging the Inevitability of Genetic Disease – Lowering the cost of Development for Gene Therapies’.
Dr Michael Caves has spent 20 years working in various academic and commercial life science settings. He has published scientific papers on biotherapeutic characterisation and formulation, and has applied this knowledge during various roles within the pharmaceutical and diagnostics industries. Having helped build the formulation development service at SGS Life Sciences, Michael joined Malvern Panalytical in 2013 in order to support customers around the world. Michael is currently based in Chennai, India, from where he focuses on helping customers across Asia’s pharmaceutical industry.
Confirmed Speakers for e-Conference on 27th May 2020
1. Matthias Gerhard Wacker, Professor, Department of Pharmacy, Faculty of Science, National Univerisity of Singapore
2. Bruno Sarmento, Principal Investigator, Nanomedicines & Translational Drug Delivery – Group Leader, INEB - Instituto de Engenharia Biomédica and i3S - Instituto de Investigação e Inovação em Saúde, Portugal
3. Gerrit Borchard, Professor, Geneva-Lausanne School of Pharmacy (EPGL), Professor at University of Geneva, Switzerland
4. Ben Boyd, Professor in Drug Delivery Sciences, Monash University, Australia
5. Gert Fricker, Director, Institute of Pharmacy & Molecular Biotechnology, Professor, Heidelberg University, Germany
6. Tivadar Feczko, Professor, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Hungary
7. Vandana Patravale, Professor of Pharmaceutics, Department of Pharmaceutical Sciences and Technology , Institute of Chemical Technology, India
8. Dirk Beilke, Head of Sales, Pharma Test AG
9. Wei Jiang Goh, Co-Founder & CEO, Craft Health
10. Dean Ho, Provost’s Chair Professor, Head of the Department of Biomedical Engineering at the National University of Singapore, Director of the N.1 Institute for Health, and Co-Founder, KYAN Therapeutics
11. Fabian Jung, Research Scientist, Pharmaceutical Technology, Fraunhofer-Institute for Molecular Biology and Applied Ecology, Germany
12. Alex van Herk, Principal Scientist & Professor, Institute of Chemical and Engineering Sciences, A*Star
13. Michael Caves, Pharma Segment Manager - APAC, Malvern Panalytical
Pour en savoir plus
More information about the nanoparticle characterisation tools discussed
NanoSight: Utilizing Nanoparticle Tracking Analysis (NTA), Malvern Panalytical’s NanoSight allows one to visualise and measure nanoparticle concentraion, particle size from 0.01 - 1 µm* in solution as well as characterise protein aggregation in real time. Hence making it a good companion for studies in viral vaccine research, nanotoxicology and biomarker detection, characterising extracellular vesicles for disease state studies. Learn from our applications team
Zetasizer Ultra: The Zetasizer Ultra is the world’s most capable combined DLS and ELS system, incorporating Non-Invasive Back Scatter (NIBS®) and, uniquely, Multi-Angle Dynamic Light Scattering (MADLS) technology for the measurement of particle and molecular size. NIBS provides the versatility and sensitivity to measure over a wide concentration range, while MADLS permits a higher resolution view into your sample’s size distribution for those critical measurements.
An extension to MADLS affords the ability to directly analyze particle concentration. The measurement of particle concentration is calibration-free, suitable for a wide range of materials, requires no or little dilution, and is quick to use – all of which make it ideal as a screening technique. This is a unique capability of the Zetasizer Ultra which can even be applied to samples such as viruses and VLPs, which were previously very challenging to measure.